Burst Pressure Test

A burst pressure test is a destructive method that increases internal pressure in a package, container, or fluid-path assembly at a controlled rate until rupture. It characterizes mechanical strength (wall, seal, weld, crimp, or bonded joint), reveals the weakest point, and quantifies margin above normal use or sterilization-transient pressures. Hydrostatic testing fills the item with liquid and pressurizes; pneumatic testing uses compressed gas. The result is typically a maximum pressure at failure (e.g., kPa, psi, bar) and a failure mode/locations log.

In regulated operations, burst testing supports multiple lifecycle intents: design verification (21 CFR 820.30 for medical devices), component qualification (21 CFR 211.94 for drug packaging), process validation and ongoing verification (21 CFR 820.75/211), and sterile barrier assurance as complementary evidence to integrity strategies (EU GMP Annex 1). Within MES, it is implemented as a parameterized operation step with recipe limits, calibrated instruments, sample traceability, and electronic records under Part 11 where applicable.

Regulators require that containers, closures, sterile barriers, and fluid paths be suitable and not adversely affect the product. For drugs, 21 CFR 211.94 requires containers/closures to protect contents; for devices, 21 CFR 820.30 and 820.75 require verified designs and validated processes. EU GMP Annex 1 expects container-closure integrity and robust packaging processes in sterile manufacturing. While no regulation mandates “burst pressure testing” by name, it is an accepted means to demonstrate seal/wall strength, set process windows, and show capability, especially when pressure excursions (e.g., sterilization cycles, transportation) are credible risks.

Burst testing is not a substitute for container-closure integrity testing (CCIT) but can underpin a control strategy: design margins, weld parameter windows, and alarm/stop interlocks on sealers. Results become part of the technical file/batch documentation, linked to sampling rationale, acceptance criteria, and investigation pathways for any out-of-specification (OOS) outcomes.

Two common configurations are hydrostatic ramp-to-failure (preferred for safety due to low stored energy) and pneumatic ramp-to-failure (faster setup, more hazardous). Key method variables include media (air, nitrogen, water), ramp rate (pressure/time), starting/ending pressures, dwell/hold segments, and failure mode categorization. Specimens must be conditioned (e.g., humidity, temperature, sterilization state) to represent worst-case. Pressure transducer range, accuracy, and sampling rate determine the fidelity of the burst peak capture, particularly for brittle or rapid failures.

Acceptance criteria are typically a minimum burst value (e.g., ≥ X psi), sometimes with a required failure mode (e.g., peel at seal rather than channel leak), drawn from design inputs, risk analysis, and historical capability. Ramp rate profoundly affects measured burst due to viscoelastic and creep behavior of polymers; standardizing the rate and documenting tolerances and actuals in the record is essential. Time-stamped pressure traces and automated peak detection improve objectivity and support SPC trending.

Define pass/fail from user needs and risk: minimum burst pressure above all credible transients with safety margin; acceptable failure modes (e.g., cohesive peel vs. adhesive delamination); and any limits on variability (Cpk/Ppk targets). For devices under QSR, design verification ties back to 21 CFR 820.30; ongoing production monitoring and process validation stages tie to 820.75. For drugs, incorporate packaging testing in accordance with 21 CFR 211 (e.g., 211.94, 211.160). Use statistically sound sampling and analysis (QSR 820.250) and document rationales in the DMR/SOPs.

• Design verification: worst-case materials, maximum seal widths, lowest process energy settings, post-sterilization aging—show margin and failure mode acceptability.
• Process validation (PQ): three lots minimum is common practice; demonstrate capability against the specification under normal operating ranges.
• Ongoing verification: SPC charts on burst results, with alarms on trends (e.g., shift in mean, increased variability) and link to preventive maintenance.
• Change control: re-verify upon material, tooling, seal recipe, or sterilization cycle changes; capture comparability study results.

Define investigation triggers beyond simple OOS (e.g., two consecutive low results near the limit; mode shift from peel to channel failure). Integrate acceptance with CCIT strategy: if CCIT shows tight margins, increase burst targets or tighten seal parameter controls. Document sampling plans and acceptance quality limits in controlled SOPs, with clear disposition rules for borderline cases.

Treat burst testers and fixtures as GxP-relevant equipment. Qualify per IQ/OQ/PQ: installation checks (utilities, shielding), operational performance (ramp-rate accuracy, sensor calibration, software alarms), and performance qualification (repeatability/reproducibility with representative samples). For devices, 21 CFR 820.72 requires suitable, calibrated measurement equipment; align computerized aspects with GAMP 5 and Part 11 where electronic records/signatures are used.

• Calibration and metrology: NIST-traceable pressure standards; cover full expected range; verify linearity and hysteresis.
• Fixtures: validate sealing against fixtures (no fixture leaks), dead volume effects, and alignment; document fixture IDs in records.
• Method robustness: vary ramp rate, temperature, and sample orientation within defined bounds; demonstrate results remain discriminating and stable.
• Measurement system analysis: conduct gage R&R for burst readings if multiple operators/fixtures are used.

Validate software functions that affect GMP data (alarm limits, auto-peak detection, audit trails, user access). Test negative scenarios (e.g., sensor fault, rate out-of-tolerance) to demonstrate safe failure and proper record flagging. Ensure e-signature workflows, time synchronization, and audit trails comply with Part 11 and MHRA data integrity expectations.

Within ISA‑95, burst testing is a Level 3 (MES) execution activity. The test step should reference master data: product/material, sample genealogy (lot/serial/UDI), equipment asset and calibration state, method version, and acceptance limits. The eBMR/eDHR captures actuals: ramp rate trace, burst pressure, failure mode annotation, operator ID, start/stop timestamps, and e-signatures. Exception handling (e.g., automatic hold when ramp-rate tolerance is exceeded) should be encoded in the recipe logic.

Feed results to SPC (Level 3 analytics) and expose summary KPIs to Level 4 (ERP/QMS) for management review. Link deviations/OOS to CAPA and change control. Ensure one-up/one-down traceability from sample to parent lot/batch and to the specific equipment/fixture used.

If burst data are acquired, stored, or approved electronically, Part 11 applies. Implement unique user credentials, role-based access, secure time-stamped audit trails for create/modify/delete, and controls for record copying and retention. E-signatures must be linked to their records and include meaning (review/approval) and date/time. Follow MHRA data integrity ALCOA+ principles for raw data (original pressure traces, not only calculated peaks) and ensure backup/recovery preserves metadata and audit trails.

Classify the tester HMI/data acquisition per GAMP 5 and validate proportionately to risk. Integrate via MES interfaces that preserve record completeness and sequence. For networked instruments, manage cybersecurity controls consistent with plant standards, and ensure time synchronization so batch/event chronology is defensible. Control templates/master data under change control, and lock test recipes once approved.

Use quality risk management to decide when burst testing is warranted and how stringent criteria should be. High-risk contexts include sterile barriers, pressurized products, thin-gauge pouches, and assemblies exposed to thermal cycles (e.g., sterilization) or altitude changes. Define margins above worst-case excursions (e.g., altitude pressure differential) and align with CCIT capability—if CCIT detects microleaks near operational pressures, increase required burst strength or tighten sealer settings.

• Map potential pressure exposures (process, logistics, end-use) and quantify maxima.
• Derive minimum burst limits with safety factors (e.g., ≥ 2× worst-case transient).
• Prioritize worst-case materials, sterilization states, and seal geometries for verification.
• Tie SPC rules to CAPA triggers and preventive maintenance (e.g., jaw wear on sealers).

Document the strategy in the control strategy and validation master plan. Ensure that any specification or sampling changes are managed under formal change control with scientific rationale and impact assessment on CCIT and shelf-life claims.

Frequent failure modes include fixture leaks misattributed as sample failures, ramp rate excursions that depress measured burst, and sample conditioning mismatches (testing non-sterilized samples for a sterilized product). Human error arises from inconsistent failure mode coding and misreading analogue gauges. Software pitfalls include overwritten raw traces, lack of audit trail for changed limits, and missing time synchronization across systems.

• Verify fixture integrity with blank tests; audit for channel leaks at interfaces.
• Automate ramp control and record actual rate; set MES interlocks if rate is out-of-tolerance.
• Capture and review raw traces; don’t rely only on peak values.
• Standardize failure mode taxonomy and train operators with visual exemplars.
• Tie sample conditioning to the method (e.g., post-sterilization, aged) with evidence.
• Trend by material lot, sealer tool, shift, and operator to detect latent patterns.

When OOS occurs, follow a documented procedure that preserves samples, reviews equipment state/calibration, confirms method execution (including ramp traces), and evaluates manufacturing impact. If invalidation isn’t justified, escalate to CAPA and risk assess affected lots, consistent with batch disposition rules.

V5 models burst testing as a controlled MES operation tied to master test methods, acceptance criteria, and equipment/fixture assets. Before execution, the system verifies calibration status, maintenance state, and software version of the tester. During execution, it acquires time-series pressure data, enforces ramp-rate tolerances with automated interlocks, and captures failure modes via guided operator prompts. Results are stored on the same record as the batch/lot and sample genealogy, with Part 11-compliant audit trails and e-signatures.

Analytics stratify results by tool, cavity, material lot, and shift; thresholds can drive preventive maintenance work orders. Data exports carry raw traces, operator annotations, and approvals for efficient regulatory inspections. Site-to-site method synchronization ensures global consistency while allowing local parameters under change control.

Monitor capability (Cpk/Ppk) for burst pressure by product/line, failure rate by lot, and distribution of failure modes. Track ramp-rate compliance as a method adherence KPI. Use control charts (X̄–R or individuals) with rules for trend, shift, and increased variability. Correlate drift with maintenance events, tool wear, or material supplier changes.

• Burst Cpk ≥ target (e.g., 1.33 or higher for critical attributes).
• % Out-of-trend (OOT) tests with root cause identified within SLA.
• Ramp-rate within tolerance on ≥ 99% of runs.
• Mean time between burst-related holds or line stops.
• Closure of corrective actions from burst-related CAPA within due dates.

Feed insights into design and supplier management: update design inputs, tighten incoming specifications, or adjust sealer recipes/windows. Ensure management review includes burst KPIs and that any specification tightening is reflected in controlled documents and validated lines.